Anders Gülfe

Treatment with tumor necrosis factor blockers is associated with a lower incidence of first cardiovascular events in patients with rheumatoid arthritis.

L. Jacobsson, Carl Turesson, Anders Gülfe et al. · PubMed · 2005 · 533 citations

Medicine, Internal Medicine, Pharmacotherapy +14

Efficacy and tolerability of anti-tumour necrosis factor therapy in psoriatic arthritis patients: results from the South Swedish Arthritis Treatment Group register

Lars Erik Kristensen, Anders Gülfe, Tore Saxne et al. · Annals of the Rheumatic Diseases · 2007 · 171 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +13

Predictors of response to anti-TNF therapy according to ACR and EULAR criteria in patients with established RA: results from the South Swedish Arthritis Treatment Group Register

L. E. Kristensen, Meliha C Kapetanovic, Anders Gülfe et al. · Lara D. Veeken · 2007 · 158 citations · Full text

Medicine, Immunology, Internal Medicine +17

Treatment response to a second or third TNF-inhibitor in RA: results from the South Swedish Arthritis Treatment Group Register

J. Karlsson, Lars Erik Kristensen, Meliha C Kapetanovic et al. · Lara D. Veeken · 2007 · 149 citations · Full text

Medicine, Immunology, Internal Medicine +16

Continuation of TNF blockade in patients with inflammatory rheumatic disease. An observational study on surgical site infections in 1,596 elective orthopedic and hand surgery procedures

Elisabet Berthold, Pierre Geborek, Anders Gülfe · Acta Orthopaedica · 2013 · 63 citations · Full text

Medicine, Orthopaedic Surgery, Orthopedic Surgery +11